Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts
Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts / Platzbecker, U., Santini, V., Komrokji, R.S., Zeidan, A.M., Garcia-Manero, G., Buckstein, R., Miteva, D., Keeperman, K., Holot, N., Nadal, J.A., Lai, Y., Vodala, S., Rosettani, B., Giuseppi, A.C., Yucel, A., Fenaux, P.. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - 37:(2023), pp. 2314-2318. [10.1038/s41375-023-02031-7]
Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts
Santini, Valeria;
2023
Abstract
Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts
| File | Dimensione | Formato | |
|---|---|---|---|
|
41375_2023_Article_2031.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
556.87 kB
Formato
Adobe PDF
|
556.87 kB | Adobe PDF | |
|
s41375-023-02031-7.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
567.18 kB
Formato
Adobe PDF
|
567.18 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
